SAPHO Syndrome - Symptoms, Diagnosis and Treatment

SAPHO Syndrome - Overview

SAPHO syndrome is a rare, chronic inflammatory condition that simultaneously affects the skin and the musculoskeletal system. The name is an acronym standing for Synovitis (inflammation of the joint lining), Acne, Pustulosis (blister-like skin lesions), Hyperostosis (abnormal bone growth) and Osteitis (bone inflammation). It belongs to the group of spondyloarthropathies and is managed by both rheumatologists and dermatologists.

SAPHO syndrome is estimated to affect approximately 1 in 10,000 people. It can occur at any age but is most commonly diagnosed between the ages of 30 and 50.

Causes and Disease Mechanisms

The exact cause of SAPHO syndrome has not yet been fully established. It is considered to have a multifactorial origin, involving the interaction of immunological, genetic and infectious factors.

• Immunological factors: SAPHO syndrome is classified as an autoinflammatory condition, in which the innate immune system triggers an excessive inflammatory response.
• Bacterial factors: Bacteria of the species Cutibacterium acnes (formerly Propionibacterium acnes) have been detected in bone biopsies of some patients, although their precise role remains unclear.
• Genetic predisposition: Familial clustering has been reported. Associations with certain HLA antigens have been observed but have not been consistently confirmed.

Symptoms

The clinical presentation of SAPHO syndrome is highly variable. Symptoms may occur individually or in combination and differ considerably between patients.

Osteoarticular Symptoms

• Osteitis and hyperostosis: Bone inflammation and thickening, most commonly affecting the anterior chest wall (sternocostoclavicular region)
• Synovitis: Inflammation of the joint lining causing swelling, pain and restricted movement
• Sacroiliitis: Inflammation of the sacroiliac joint, similar to ankylosing spondylitis
• Spinal involvement: Inflammatory changes along the spine are possible

Dermatological Symptoms

• Palmoplantar pustulosis: Pustules on the palms of the hands and soles of the feet
• Severe acne: Acne conglobata or acne fulminans
• Psoriasis: Present in a proportion of patients

Joint symptoms may precede, coincide with or follow skin manifestations. In some patients, skin involvement is entirely absent.

Diagnosis

Diagnosing SAPHO syndrome is frequently challenging and may take several years, owing to its rarity and the diversity of its clinical features.

Diagnostic Criteria

The most widely used criteria, proposed by Kahn and Kahn (1994), identify four diagnostic constellations:

1. Severe acne or hidradenitis suppurativa combined with osteitis or arthritis
2. Palmoplantar pustulosis combined with osteitis or arthritis
3. Hyperostosis with or without skin involvement
4. Chronic recurrent multifocal osteomyelitis in children

Imaging

• X-ray: Detection of hyperostosis and osteosclerotic changes
• MRI: Early identification of inflammatory bone changes
• Bone scintigraphy: The characteristic "bull's head" pattern in the sternocostoclavicular region

Laboratory Tests

No specific laboratory markers exist for SAPHO syndrome. General inflammatory markers such as ESR and CRP are frequently elevated. HLA-B27 may be positive but is not a consistent finding.

Treatment

No curative treatment for SAPHO syndrome is currently available. Therapy focuses on controlling inflammation and alleviating symptoms.

Pharmacological Treatment

• NSAIDs: First-line therapy for pain relief and anti-inflammatory effect
• Bisphosphonates: Pamidronate and zoledronic acid have shown efficacy in osteitis
• DMARDs: Methotrexate, sulfasalazine and leflunomide are used in severe cases
• Biologics: TNF-alpha inhibitors (such as adalimumab and etanercept) as well as IL-1 and IL-17 inhibitors show increasing clinical benefit
• Antibiotics: In selected cases with suspected bacterial involvement (e.g. doxycycline, azithromycin)
• Corticosteroids: Short-term use for acute inflammation, not suitable for long-term management

Non-Pharmacological Treatment

Physiotherapy and exercise therapy are important components of the overall treatment plan. They help to maintain joint function and reduce pain. An anti-inflammatory diet rich in relevant nutrients may provide additional support during treatment.

For people with chronic inflammatory joint conditions such as SAPHO syndrome, targeted nutritional support for the joints can play a complementary role. Our joint complex with UC-II collagen for targeted joint nutrient support has been formulated specifically for individuals with joint concerns.

Disease Course and Prognosis

SAPHO syndrome typically follows a chronic course with alternating flares and remissions. Some patients experience spontaneous remission over time, while others develop progressive bone changes. Early diagnosis and consistent treatment improve the long-term outlook.

Quality of life may be significantly affected by chronic pain, restricted movement and the visible nature of skin lesions. Multidisciplinary care involving rheumatologists, dermatologists and physiotherapists is recommended.

To support joint health in everyday life, our joint complex with natural UC-II collagen and joint-active nutrients offers a complementary option for those affected by joint inflammation.

Differentiation from Similar Conditions

SAPHO syndrome must be distinguished from other rheumatic and dermatological conditions, including:

• Psoriatic arthritis
• Ankylosing spondylitis
• Reactive arthritis
• Infectious osteomyelitis
• Crohn's disease with joint involvement

Differential diagnosis requires careful clinical, laboratory and imaging evaluation by specialists. For individuals managing chronic joint inflammation, our UC-II joint complex supplement may provide supportive nutritional care alongside prescribed medical treatment.

Frequently Asked Questions

What does the acronym SAPHO stand for?

SAPHO stands for Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis. The acronym describes the characteristic clinical features of this rare chronic inflammatory disorder affecting both the skin and the skeletal system. Not all patients present with every component simultaneously.

How is SAPHO syndrome diagnosed?

Diagnosis is based on the characteristic combination of skin and musculoskeletal findings, supported by imaging techniques such as X-ray, MRI and bone scintigraphy. There are no specific blood tests. The diagnosis is often delayed by several years due to the rarity of the condition and its overlap with other rheumatic diseases.

Is SAPHO syndrome curable?

There is currently no known cure for SAPHO syndrome. However, many patients achieve periods of remission with appropriate treatment. The goal of therapy is to control disease activity, reduce pain and preserve quality of life. The prognosis varies considerably between individuals.

Which specialists treat SAPHO syndrome?

SAPHO syndrome affects both joints and skin, requiring a multidisciplinary approach. Rheumatologists and dermatologists are the primary specialists involved. Depending on the clinical picture, orthopaedic surgeons, physiotherapists and other healthcare professionals may also contribute to care.

Is SAPHO syndrome related to psoriasis?

There is an established clinical overlap between SAPHO syndrome and psoriasis. A proportion of SAPHO patients also have psoriatic skin disease, and some experts classify SAPHO within the psoriatic arthritis spectrum. Both conditions share autoinflammatory immune mechanisms involving similar cytokine pathways.

What dietary approach may support people with SAPHO syndrome?

An anti-inflammatory diet rich in omega-3 fatty acids, antioxidants, vegetables and whole grains may help to modulate chronic inflammatory processes. Reducing the intake of highly processed foods and added sugars is generally advisable. Individual nutritional counselling is recommended for people with chronic inflammatory conditions.

References

1. Kahn MF, Kahn MA. The SAPHO syndrome. Baillieres Clin Rheumatol. 1994;8(2):333-362.
2. Nguyen MT, Borchers A, Selmi C, et al. The SAPHO syndrome. Semin Arthritis Rheum. 2012;42(3):254-265. doi:10.1016/j.semarthrit.2012.05.006
3. Firinu D, Garcia-Larrea L, Murenu A, et al. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment. Curr Rheumatol Rep. 2016;18(6):35. doi:10.1007/s11926-016-0583-y